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Abstract
Background
Postoperative respiratory failure (PRF, namely mechanical ventilation >48 hours) signifi-
cantly affects morbidity and mortality in liver transplantation (LTx). Previous studies ana-
lyzed only one or two categories of PRF risk factors (preoperative, intraoperative or
postoperative ones).
The aims of this study were to identify PRF predictors, to assess the length of stay (LoS)
in ICU and the 90-day survival according to the PRF in LTx patients.
Methods
Two classification approaches were used: systematic classification (recipient-related preop-
erative factors; intraoperative factors; logistic factors; donor factors; postoperative ICU fac-
tors; postoperative surgical factors) and patient/organ classification (patient-related general
factors; native-liver factors; new-liver factors; kidney factors; heart factors; brain factors;
lung factors). Two hundred adult non-acute patients were included. Missing analysis was
performed. The competitive role of each factor was assessed.
Results
PRF occurred in 36.0% of cases. Among 28 significant PRF predictors at univariate analy-
sis, 6 were excluded because of collinearity, 22 were investigated by ROC curves and by
logistic regression analysis. Recipient age (OR = 1.05; p = 0.010), female sex (OR = 2.75;
p = 0.018), Model for End-Stage Liver Disease (MELD, OR = 1.09; p<0.001), restrictive lung
pattern (OR = 2.49; p = 0.027), intraoperative veno-venous bypass (VVBP, OR = 3.03; p =
0.008), pre-extubation PaCO2 (OR = 1.11; p = 0.003) and Model for Early Allograft Function
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(MEAF, OR = 1.37; p<0.001) resulted independent PRF risk factors. As compared to
patients without PRF, the PRF-group had longer LoS (10 days IQR 7–18 versus 5 days IQR
4–7, respectively; p<0.001) and lower day-90 survival (86.0% versus 97.6% respectively,
p<0.001).
Conclusion
In conclusion, MELD, restrictive lung pattern, surgical complexity as captured by VVBP,
pre-extubation PaCO2 and MEAF are the main predictors of PRF in non-acute LTx patients.
Introduction
Postoperative pulmonary complications occur in 5 to 10% of surgical patients, and in 9 to 40%
abdominal surgical patients [1–3]. Infectious and non-infectious pulmonary complications are
the main cause of early postoperative morbidity, early mortality, and increased hospital stay
[1–3]. Postoperative respiratory failure (PRF), defined as the need for mechanical ventilation
for more than 48 hours after surgery is among the most serious postoperative pulmonary com-
plications [3–4].
Candidates to liver transplantation (LTx) exhibit several concomitant morbidities and have
to face the effects of an extremely invasive surgery, sometimes complicated by massive bleed-
ing. Moreover, the transplant procedure itself implies bilateral transection of the abdominal
muscles, insult on chest wall related to retractor, and diaphragmatic impairment [5–9]. Finally,
in patients with primary non-function of the graft and related dysfunction of other organs
(severe encephalopathy, hemodynamic instability, renal failure), the need for an urgent re-
transplant contraindicates the liberation from mechanical ventilation.
Several factors including age, female sex, degree of liver decompensation, previous lung
abnormalities, renal impairment, diabetes, and preoperative donor data have been variably
associated with pulmonary complications or specifically with PRF [6,10–18]. In general, com-
parison among studies is impaired by the different definitions and timings adopted for end-
point evaluation. In addition, no study has defined the relevance of potential risk factors for
PRF by excluding collinearity and Odd Ratios (OR) are available only in few studies [12–16].
Overall, intraoperative surgical complexity has been investigated only in terms of transfusion
needs [11,13–16], while the relationship between PRF and postoperative graft recovery has
been scarcely explored [11,13,19].
The aim of this study is to investigate risk factors for PRF in LTx patients, as well as the PRF
impact on the prognosis.
Materials and methods
Study design
This retrospective study was designed to identify potential risk factors for PRF (primary end-
point) and to estimate the length of stay (LoS) in ICU and day 90-survival according to PRF
(secondary end-points) in LTx patients. Adult patients admitted to the postoperative Intensive
Care Unit (ICU) of Fondazione Policlinico Universitario A.Gemelli IRCCS of Rome between
January 2010 and August 2017 were included. LoS was calculated as the difference in days
from the day of discharge (ICU or hospital) and the day of transplant. Patients who died
in ICU or hospital were excluded from LoS calculation. The study was approved by the
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EF, Extubation Failure; FiO2, Fraction of Inspired
Oxygen; HCC, Hepatocellular Carcinoma; ICU,
Intensive Care Unit; IQR, Interquartile Range; LoS,
Length of Stay; LTx, Liver Transplantation; MEAF,
Model for Early Allograft Function; MELD, Model
for End-Stage Liver Disease; MELDNa, Model for
End-Stage Liver Disease Sodium; OR, Odd Ratio;
PaCO2, partial pressure of arterial CO2; PaO2,
partial pressure of arterial oxygen; pod,
postoperative day; PRF, Postoperative Respiratory
Failure; RIFLE, Risk Injury Failure Loss End-stage
of kidney disease; ROC, Receiver Operator
Characteristic; SAPS, Simplified Acute Physiology
Score; SD, Standard Deviation; VVBP, veno-venous
bypass; WF, Weaning Failure.
Institutional Review Board of “Istituto di Anestesiologia e Rianimazione” of Fondazione Poli-
clinico Universitario A.Gemelli IRCCS, Rome, Italy.
Data
We used a routinely-collected anonymous data set on liver transplants, prospectively gathered
at our institution. We counted the number of missing data for each variable and we included
only variables with a percentage of missing less than or equal to 8%. Variables relevant to the
study purpose are shown in S1 Table. Multivariable analysis was performed on the same num-
ber of observations.
Echocardiography, pulmonary function tests, and arterial blood gas analyses were obtained
as a part of the routine preoperative evaluation. The pulmonary defect pattern was defined as
obstructive in presence of a forced expiratory flow in 1 second / forced vital capacity ratio
�70% of the predicted value, or as restrictive if the total lung capacity was <80% of the pre-
dicted value [20]. Restrictive pattern was defined according to the percentage of predicted total
lung capacity: mild (�70%), moderate (60–69%) and severe (<60%) [20]. Pleural effusion was
defined as moderate-severe when the estimation by ultrasonography suggested a volume
greater than 500 mL [21]. Ascites was defined as mild (<5 L) or moderate-severe (�5 L)
according to the intraoperative aspiration. Hepatic encephalopathy grade was defined accord-
ing to West Haven criteria [22]. Intraoperative fluid balance was monitored through Swan-
Ganz catheter and esophageal Doppler. Crystalloids were administered (3–5 mL/Kg/h) to
maintain a central venous pressure target of 5 mmHg and avoid bleeding from liver bare areas;
each major hemodynamic change was counteracted by crystalloids and/or vasoactive drugs
administration. Postoperatively, a slightly negative fluid balance was maintained. The value of
9 g/dL of hemoglobin was adopted as target for transfusion.
Patients were considered ready for weaning from mechanical ventilation according to fol-
lowing criteria: hemodynamic stability, body temperature <38˚ C, pressure support�8 cm
H2O with positive end-expiratory pressure�5 cm H2O, SaO2 >90% on FiO2�0.4, respiratory
rate�35 breaths/min, maximal inspiratory pressure�20 cm H2O, tidal volume >5 ml/Kg,
rapid shallow breathing index<105 breaths/min/L, no respiratory acidosis and adequate level
of consciousness [23]. PRF was defined as the need for mechanical ventilation for more than
48 hours after transplantation or the reinstitution of mechanical ventilation (invasive or non-
invasive) at any time during the ICU stay after liver transplantation [16]. PRF patients were
further grouped as weaning failure (WF) patients if not fulfilled weaning criteria at 48 h after
transplant or as extubation failure (EF) patients if they were extubated within 48 hours but
required the reinstitution of mechanical ventilation, either through reintubation or non-inva-
sive ventilation, according to the tolerability of non-invasive ventilation interface and gas
exchange efficacy [24]. Tracheotomy was performed in patients needing ventilation for more
than 10 days. Infectious postoperative pulmonary complications were defined according to the
American Society of Infectious Disease guidelines criteria [25].
Scores
Eleven scores were included in the analyses. Seven scores refer to organ functions and include
Model for End-stage Liver Disease (MELD) [26] and MELDNa at listing [27], MELD and
MELDNa at transplant, MELD at day 3 post operation (3-pod) [28], Model for Early Allograft
Function (MEAF) [29], and Risk Injury Failure Loss End-stage of kidney disease (RIFLE) [30].
Two additional scores, donor age x MELD (D-MELD) [31], and BAlance of Risk [32] regard
the match between quality of the donor and disease severity of the patient. One score, the Sim-
plified Acute Physiology Score (SAPS II), refers to a multisystem evaluation of critical patients
Risk factors for respiratory failure in liver transplantation
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[33]. The Dindo-Clavien score obtained at hospital discharge [34] was used only to provide an
efficacious stratification among groups and subgroups in terms of complication prevalence.
Allocation, surgery, graft perfusion and immunosuppressive therapy. Cirrhotic
patients were prioritized for transplantation according to the disease severity and ranked by
MELD score [26]. Patients with hepatocellular carcinoma (HCC) were equalized to cirrhotic
ones according to the Italian allocation system, deserving attention to donor-recipient match
[31,35–38]. The operation was performed in order to minimize the ischemia time. The hepa-
tectomy started when the donor team was on the way back. Cases with delay in the graft avail-
ability were managed at the end of hepatectomy by VVBP or termino-lateral temporal porto-
caval anastomosis. Split livers (n = 2) were performed in situ. The grafts were perfused with
University of Wisconsin or Histidine-Tryptophan-Ketoglutarate solution, as previously
reported [39]. All patients received immunosuppressive therapy consisting of the combination
of calcineurin inhibitors (cyclosporine or tacrolimus), mofetyl-micophenolate and low-dose
steroids starting on postoperative day 0. In cases with renal impairment, calcineurin inhibitors’
administration was postponed and introduced at adjusted doses according with renal function
recovery. Biopsy proven rejection episodes were treated with steroid boluses and, if resistant,
with anti-thymocyte polyclonal globulins.
Risk assessment
The overall risk was assessed combining risk factors according to a systematic classification
and to a patient- and organ- specific classification (Table 1).
The competitive contribution of different factors to PRF was investigated. Non-collinear
variables resulting more robustly associated with PFR were then combined in logistic analyses
to quantify the impact of strongest factors in each category.
Statistical analysis
Data were expressed as continuous or dichotomous variables. Continuous variables were
reported as mean ± SD or as median and IQR. Dichotomous variables were reported as abso-
lute (number) and relative (percentage) frequency. According to guidelines on statistical stud-
ies in organ transplantation [42], missing data relative to study covariates involved always less
than 8.0% of cases. The incidence of PRF was compared between different patient groups
using Chi squared test. Continuous variables were compared between patients with and with-
out PRF using Student’s t-test. Multivariate logistic regression analysis was performed to iden-
tify factors associated with PRF.
The relationship between factors and PRF was reported as Odd Ratio (OR) and 95% confi-
dence intervals (CI). Due to the large number of potential factors, only those with p�0.1 at
univariate analysis were considered. According to the backward stepwise selection approach,
variables with p>0.1 were eliminated. The goodness of fit of the final model was assessed using
the Hosmer-Lemeshow test [43].
In order to avoid multicollinearity among similar parameters (for example, MELD vs
MELDNa at the transplant) the potentially most performing parameters were identified using
variance inflation factor statistics and ROC curve methodology [44]. Survival was expressed as
patient survival and assessed by Kaplan Meier method and log-rank test. All analyses were per-
formed with SPSS version 25.0 (Chicago, IL).
Results
Overall, 212 consecutive transplants performed in 210 adult patients were identified. Twelve
transplants were excluded (8 acute liver failure, 1 death at ICU arrival, 1 tracheotomy before
Risk factors for respiratory failure in liver transplantation
PLOS ONE | https://doi.org/10.1371/journal.pone.0211678 February 11, 2019 4 / 18
LTx, and 2 early re-transplants due to primary non-function of the graft). In total, 200 trans-
plants in 200 patients were studied. (S1 Fig). Among 200 patients, 7 had been previously
admitted to the ICU (2 pneumonia, 2 variceal bleeding and 3 sepsis) and discharged before
LTx. In contrast, 3 patients requiring hemofiltration were transplanted while staying in ICU.
All patients arrived to ICU intubated and mechanically ventilated as per our protocol. Patients’
characteristics of the study population are summarized in Table 2.
Predictors of PRF at univariate analysis
Clinical characteristics of patients with and without PRF are summarized in Table 2 and S1
Table. PRF was observed in 72 (36.0%) out of 200 transplants. PRF and no-PRF cases had simi-
lar age, BMI and prevalence of diabetes and HCC. A higher proportion of cases in the PRF
group were female, required pre-transplant or post-transplant hemofiltration, presented grade
Table 1. Dual-perspective approach to potential risk factors.
A. Systematic approach Potential risk factors
A1. Preoperative factors related
to the recipient
Age at transplant; Sex; BMI; Indication; Diabetes; MELD at transplant;
MELDNa at transplant; Hemofiltration; Left Ventricular Ejection Fraction
percentage; Systolic pulmonary artery pressure; Diastolic dysfunction; pH;
PaO2 and PaCO2 at listing; Restrictive or Obstructive pattern at Pulmonary
Function Tests; Encephalopathy grade; Hepatopulmonary syndrome;
Portopulmonary syndrome
A2. Intraoperative factors VVBP; Porto-caval anastomosis; transfusion requirements (Packet red
blood cells, Fresh frozen plasma, Platelets); Operation time
A3. Logistic factors D-MELD; BAR; CIT
A4. Donor factors Donor age; Standard donor/non-standard donor [40]; Extended criteria
donor/non-extented criteria donor [41]
A5. Postoperative ICU factors Hemofiltration or Hemodialysis; SAPS II; Mechanical Ventilation; PaO2;
PaCO2; PaO2/FiO2 ratio; Post-operative Pulmonary Complications
A6. Postoperative surgical factors MEAF; MELD at the 3rdpod; RIFLE at the 3rdpod (2–3 versus 0–1);
creatinine at the 3rdpod
B. Patient or organ based approach
B1. General factors (patient) Age at transplant; Sex; BMI; Diabetes; SAPS II
B2. Native-liver factors Indication; MELD at listing; MELD at transplant; MELDNa at listing;
MELDNa at transplant; Hepatopulmonary syndrome; Portopulmonary
syndrome; VVBP; Transfusion requirements (Packet red blood cells, Fresh
frozen plasma, Platelets)
B3. New-liver factors Donor Age; Standard donor/non-standard donor [40]; Extended criteria
donor/non-extented criteria donor [41]; D-MELD; BAR; MEAF; MELD at
the 3rdpod; CIT; Operation time
B4. Kidney factors Hemofiltration; RIFLE at the 3rdpod; creatinine at the 3rdpod
B5. Heart factors Left Ventricular Ejection Fraction percentage; Systolic Pulmonary Artery
Pressure; Diastolic dysfunction
B6. Brain factors Encephalopathy grade
B7. Lung factors Mechanical Ventilation; pH, PaO2, and PaCO2 at listing; pre-extubation
PaO2, PaCO2 and PaO2/FiO2ratio; post-extubation PaO2, PaCO2 and PaO2/
FiO2ratio; Restrictive or Obstructive pattern at Pulmonary Function Tests;
Post-operative Pulmonary Complications
BMI: body mass index, MELD: Model for End-stage Liver Disease, PaO2: partial pressure of arterial oxygen, PaCO2:
partial pressure of arterial CO2, VVBP: Veno-Venous Bypass, D-MELD: Donor Model for End-stage Liver Disease,
BAR: BAlance of Risk score, CIT: Cold Ischemia Time, ICU: Intensive Care Unit, SAPS: Simplified Acute Physiology
Score, FiO2: Fraction of Inspired Oxygen, MEAF: Model for Early Allograft Function, RIFLE: Risk Injury Failure
Loss End-stage of kidney disease
https://doi.org/10.1371/journal.pone.0211678.t001
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Table 2. Characteristics of the study population and comparison between PRF and no-PRF cases (univariate analysis).
Factors All (n = 200)
Median (IQR/ Mean±SD/n (%)
Missing
n (%)
PRF (n = 72)
Median (IQR)/ Mean±SD/n (%)
no-PRF (n = 128)
Median (IQR)/ Mean±SD/n (%)
P value
PREOPERATIVE FACTORS (Recipient)
Age (years) 56 (48–62) 0 (0) 56 (48–62) 56 (48–62) 0.90
Female sex 40 (20.0) 0 (0) 22 (30.6) 18 (14.1) 0.05
BMI 25.6 ± 3.9 0 (0) 25.3 ± 3.9 25.8 ± 3.9 0.37
HCC 75 (37.5) 0 (0) 28 (38.9) 47 (36.7) 0.76
MELD at LTx 18 (13–24) 0 (0) 22 (15–30) 17 (12–21) 0.05
MELD in HCC pts 13 (11–18) 0 (0) 15 (12–19) 12 (10–15) 0.02
MELD in no-HCC pts 21 (16–27) 0 (0) 25 (17–32) 20 (15–24) <0.01
MELDNa at LTx 21 (15–28) 0 (0) 24 (16–32) 20 (14–25) 0.01
MELDNa in HCC pts 16 (12–21) 0 (0) 19 (14–23) 15 (11–20) 0.07
MELDNa in no-HCC pts 24 (19–30) 0 (0) 29 (22–33) 22 (18–27) <0.01
Encephalopathy grade�2 7 (3.5) 0 (0) 4 (5.6) 3 (2.3) <0.01
TLC (% of predicted) 91.4 ± 14.9 0(0) 88.0 ± 17.0 92.4 ± 13.6 0.02
FEV1 (% of predicted) 92.6 ± 17.3 0(0) 87.8 ± 19.5 95.3 ± 15.4 0.01
FVC (% of predicted) 96.9 ± 18.0 0 (0) 92.0 ± 20.5 99.9 ± 15.9 <0.01
Restrictive pattern 41 (20.5) 0 (0) 21 (29.2) 20 (15.6) <0.01
Obstructive pattern 14 (7.0) 0 (0) 6 (8.3) 8 (6.3) 0.82
INTRAOPERATIVE FACTORS
Portal vein thrombosis 15 (7.5) 5 (2) 9 (12.5) 6 (4.7) 0.04
VVBP 41 (20.5) 0 (0) 23 (31.9) 18 (14.1) <0.01
Porto-caval anastomosis 10 (5.0) 0 (0) 6 (8.3) 4 (3.1) 0.11
Packed red blood cell (units) 10.6 ± 9.0 0 (0) 13.0 ± 10.0 9.1 ± 8.0 <0.01
Packed red blood cell >10 units 79 (39.5) 0 (0) 40 (55.6) 39 (30.5) <0.01
Fresh Frozen Plasma (units) 16.8 ± 16.6 0 (0) 18.8 ± 17.7 15.5 ± 15.7 0.16
Platelets (units) 1.24 ± 1.4 0 (0) 1.69 ± 1.58 0.99 ± 1.20 <0.01
Operation time (hours) 12 (11–13) 3 (1) 12 (11–14) 11 (10–13) 0.03
LOGISTIC FACTORS
D-MELD at LTx 985 ± 529 0 (0) 1131 ± 586 903 ± 477 0.46
BAR 6.8 ± 4.3 7 (3) 8.1 ± 4.8 6.1 ± 3.7 0.13
CIT (hours) 8 (7–8) 4 (2) 8 (7–9) 8 (7–8) 0.05
DONOR Factors
Age (years) 55 (38–67) 0 (0) 56 (43–68) 55 (38–66) 0.95
Non-standard donor 82 (41.0) 16 (8) 34 (47.2) 48 (37.5) 0.21
Extended criteria donor 94 (47.0) 16 (8) 37 (51.4) 57 (44.5) 0.31
POST-OPERATIVE ICU factors
SAPS II at ICU admission 36.1 ± 15.3 16 (8) 40.1 ± 15.6 33.8 ± 14.7 <0.01
PaO2 pre-extubation (mmHg) 147.8 ± 35.8 5 (2) 144.2 ± 31.5 149.0 ± 39.0 0.37
PaCO2 pre-extubation (mmHg) 36.5 ± 5.4 2 (1) 38.8 ± 5.6 34.5 ± 5.0 0.02
PaO2/FiO2 pre-extubation 369 ± 104 5 (2) 352 ± 87 380± 111 0.08
POST-OPERATIVE SURGICAL factors
MEAF 4.9 ± 2.0 0 (0) 5.7 ± 2.0 4.5 ± 1.9 <0.01
MEAF 8 or higher 18 (9.0) 0 (0) 12 (16.7) 6 (4.7) <0.01
MELD at the 3rdp.o.d. 15.9 ± 7.3 7 (3) 19.0 ± 7.0 14.2 ± 7.0 <0.01
Bilirubin at the 3rd p.o.d(mg/dl) 5.2 ± 4.3 0 (0) 2.4 ± 0.8 1.8 ± 0.8 <0.01
RIFLE at the 3rdp.o.d. 0.43 ± 0.78 0 (0) 0.60 ± 0.90 0.33 ± 0.69 0.03
Creatinine at the 3rdp.o.d. (mg/dl) 1.29 ± 0.67 0 (0) 1.48 ± 0.68 1.18 ± 0.65 <0.01
(Continued)
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�2 encephalopathy or hepatopulmonary syndrome. Pulmonary function tests were altered in
55 out of 200 patients (restrictive pattern in 41 cases, 20.5% and obstructive pattern in 14
cases, 7.0%). Overall, the presence of restrictive pattern was significantly associated with PRF
(Table 2). Among PRF patients with restrictive pattern, moderate-severe pleural effusion was
observed in 35 cases (85.3%) and moderate-severe ascites was present in 12 cases (53.6%). On
the whole, PRF cases exhibited higher values of MELD and MELDNa at transplant. In particu-
lar, MELD was higher in PRF patients independently from the HCC status, whereas, MELD in
PRF patients with HCC was lower than in PRF without HCC (Fig 1).
PRF cases showed a higher incidence of portal thrombosis, received a higher number of
packed red blood cell and platelet units, and more frequently required veno-venous bypass
(VVBP). Furthermore, PRF patients displayed higher D-MELD, whilst Cold Ischemia Time
(CIT) was moderately increased. The operation time in the PRF group was longer than in no-
PRF group. Similarly, PRF cases had higher SAPS II scores at ICU admission. After surgery, PRF
patients exhibited higher pre-extubation PaCO2 levels. Overall, 22 patients (11.0%) developed
pneumonia, mostly in the PRF group (20, 27.8%). MEAF (evaluated as continuous variable and
as percentage of patients with MEAF score>8), MELD at the 3rd pod, bilirubin at the 3rd pod,
RIFLE and creatinine at the 3rd pod were higher in PRF cases. Accordingly, PRF cases suffered a
higher incidence of severe complications as assessed by the Clavien-Dindo stratification.
Predictors of PRF at ROC and multivariate analysis
Among the 28 PRF predictors at univariate analysis, hemofiltration and pre-LTx mechanical
ventilation were not included for the exiguous number of positive cases. Six parameters were
Table 2. (Continued)
Factors All (n = 200)
Median (IQR/ Mean±SD/n (%)
Missing
n (%)
PRF (n = 72)
Median (IQR)/ Mean±SD/n (%)
no-PRF (n = 128)
Median (IQR)/ Mean±SD/n (%)
P value
OTHER DATA (available after 48 hours)
PaO2 post-extubation (mmHg) 115.8 ± 34.8 15 (8) 103.1 ± 33.9 123.4 ± 32.3 <0.01
PaCO2 post-extubation (mmHg) 37.5 ± 6.0 15 (8) 39.2 ± 6.8 36.4 ± 5.1 <0.01
PaO2/FiO2 post-extubation 283 ± 93 15 (8) 255 ± 100 300 ± 85 <0.01
Mechanical Ventilation (hours) 22 (17–44) 0 (0) 61 (35–91) 20 (16–25) <0.01
Non-infectious lung involvement 113 (56.5) 0 (0) 53 (73.6) 60 (46.9) <0.01
Pneumonia 22 (11.0) 0 (0) 20 (27.8) 2 (1.6) <0.01
Clavien-Dindo stratification
Grade 0 60 (30.0) 0 (0) 7 (9.7) 53 (41.4) <0.01
Grade 1 49 (24.5) 0 (0) 15 (20.8) 34 (26.6) 0.36
Grade 2 37 (18.5) 0 (0) 15 (20.8) 22 (17.2) 0.52
Grade 3A 13 (6.5) 0 (0) 7 (9.7) 6 (4.7) 0.17
Grade 3B 12 (6.0) 0 (0) 7 (9.7) 5 (3.9) 0.05
Grade 4 15 (7.5) 0 (0) 9 (12.5) 6 (4.7) 0.04
Grade 5 14 (7.0) 0 (0) 12 (16.7) 2 (1.6) <0.01
Grade 3B and higher 41 (20.5) 0 (0) 28 (38.9) 13 (10.2) <0.01
PRF: Postoperative Respiratory Failure, IQR: interquatile range, BMI: body mass index, LTx: Liver Transplantation, HCC: Hepatocellular carcinoma, MELD: Model for
End-stage Liver Disease, LVEF%: Left Ventricular Ejection Fraction percentage, SPAP: Systolic Pulmonary Arterial Pressure, PPS: porto-pulmonary syndrome, PaO2:
partial pressure of arterial oxygen, PaCO2: partial pressure of arterial CO2, TLC: Total Lung Capacity, FEV1: Forced Expiratory Flow in 1 second, FVC: Forced Vital
Capacity, VVBP: Veno-Venous bypass, D-MELD: Donor Model for End-stage Liver Disease, BAR: BAlance of Risk score, CIT: Cold Ischemia Time, ICU: Intensive
Care Unit, SAPS: Simplified Acute Physiology Score, FiO2: Fraction of Inspired Oxygen, MEAF: Model for Early Allograft Function, RIFLE: Risk Injury Failure Loss
End-stage of kidney disease
https://doi.org/10.1371/journal.pone.0211678.t002
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excluded because of collinearity. The remaining 22 parameters were investigated by ROC
curve (Fig 2, S2 Table) and logistic regression analyses.
In addition, recipient age was included for epidemiologic reasons. Logistic regression analy-
sis showed the following independent risk factors: recipient age (OR = 1.05; 95%CI 1.01–1.09;
Fig 1. Frequencies of MELD in no-HCC and HCC patients. (A) Histograms of MELD according to the outcome (PRF vs no-PRF) are reported. For each subset
mean ± SD and median (IQR) are reported. (B) Frequencies and (percentages) are reported in PRF and no-PRF patients according to MELD�22 and MELD<22.
https://doi.org/10.1371/journal.pone.0211678.g001
Risk factors for respiratory failure in liver transplantation
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Fig 2. ROC curve analysis. The Areas Under the Curve and Standard Errors are reported under each subset.
https://doi.org/10.1371/journal.pone.0211678.g002
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p = 0.010), female sex (OR = 2.79; 95%CI 1.19–6.52; p = 0.018), MELD at transplant
(OR = 1.09; 95%CI 1.04–1.14; p<0.001), lung restrictive pattern (OR = 2.49; 95%CI 1.11–5.61;
p = 0.027), VVBP (OR = 3.03; 95%CI 1.33–6.90; p = 0.008), pre-extubation PaCO2 (OR = 1.11;
95%CI 1.03–1.18; p = 0.003) and MEAF (OR = 1.37; 95%CI 1.15–1.63; p<0.001). Overall, 198
out of 200 observations with a full set of confounders were included in the multivariate analy-
sis, The analysis displayed an excellent Hosmer-Lemeshow test value indicative of goodness of
fit (p = 0.88). Detailed data are reported in S3 Table.
Univariate analysis according to the type of PRF
Among PRF cases, 44 (61.1%) were attributable to WF and 28 (38.9%) to EF. Main causes of
WF were hemodynamic instability, alveolar-interstitial pulmonary edema (frequently transfu-
sion-associated circulatory overload in patients with massive bleeding), neurological
impairment, and pending surgical issues (abdominal packing). In contrast, in EF cases, reinsti-
tution of mechanical ventilation was mainly due to copious tracheal secretions with ineffective
cough and atelectasis and concomitant respiratory muscle fatigue.
Demographic and clinical characteristics of EF and WF patients are shown in Table 3 and
in S4 Table.
On the whole, WF cases showed significantly higher values of MELDNa than EF patients,
while MELD values were only slightly increased. Regarding intraoperative variables, WF cases
showed a higher prevalence of VVBP (p = 0.04). Among additional postoperative data, EF
cases displayed lower post-extubation PaO2/FiO2 ratio, lower rate of severe surgical complica-
tions, and lower ICU mortality rate (Fig 3).
Length of stay, discharge and survival
Overall, LoS in ICU was 6 days (IQR 5–10 day). No-PRF cases had a median LoS of 5 days
(IQR 4–7 day) and were all discharged from ICU. In contrast, PRF ones had a significantly
higher LoS (10 days, IQR 7–18 day, p<0.001) in comparison with no-PRF patients. The LoS
was similar in EF and WF groups (Table 3). The day-90 survival was 97.6%±1.4 in the no-PRF
group (one patient died at the 80th postoperative day for intractable ascites and sepsis) and
86.0%±4.1 in the entire PRF group (p<0.001). Among PRF patients, 90-day survival was
96.4%±3.5% and 79.2%±6.2% in the EF and WF subgroups, respectively (p = 0.047) (Fig 3).
Discussion
The reported incidence of PRF in liver transplantation ranges between 11% and 42% due to
the different thresholds used to define “prolonged” mechanical ventilation (from 24 hours to
7.5 days), and to the different inclusion criteria [11–18]. Overall, the incidence of PRF in our
study population is 36.0%. We found that PRF is affected by seven independent variables,
including MELD at transplant, restrictive lung pattern, use of VVBP, MEAF, pre-extubation
PaCO2, patient age and sex. Remarkably, many variables considered in our analysis, such as
intraoperative surgical factors (portal thrombosis and porto-caval anastomosis) or logistic risk
factors (D-MELD, BAlance of Risk, CIT) have been never investigated, neither collinearity was
ruled out in previous studies [6,11–18]. Furthermore, this is the first study including the
MEAF in a multivariable prediction model for PRF.
Among the identified PRF risk factors, MELD at transplant, restrictive lung pattern and use
of VVBP resulted the most relevant. The role of MELD [13,14,17] and restrictive lung pattern
[16] has been previously evidenced. Notably, our study population includes two well-defined
groups: high-MELD no-HCC patients and low-MELD HCC patients, and both groups have
similar PRF prevalence. Regarding the restrictive lung pattern, it mainly resulted from pleural
Risk factors for respiratory failure in liver transplantation
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Table 3. Characteristics of PRF patients according to extubation and weaning failure (univariate analysis).
Factors Extubation failure (n = 28)
Median (IQR) /
Mean ± SD/n (%)
Weaning failure (n = 44)
Median (IQR) /
Mean±SD /n (%)
P value
PREOPERATIVE FACTORS (recipient)
Age (years) 58 (50–62) 54 (47–62) 0.90
Female sex 8 (28.6) 14 (31.8) 0.77
BMI >30 2 (7.1) 9 (20.5) 0.13
HCC 11 (39.3) 17 (38.6) 0.96
MELD at LTx 20 (14–26) 23 (15–31) 0.06
MELDNa at LTx 23 (16–30) 27 (15–33) 0.01
Encephalopathy grade�2 2 (7.1) 2 (4.5) 0.22
Restrictive pattern 7 (25.0) 14 (31.8) 0.56
Obstructive pattern 3 (10.7) 3 (6.8) 0.62
INTRAOPERATIVE factors
Portal Vein thrombosis 2 (7.1) 7 (15.9) 0.26
VVBP 5 (17.9) 18 (40.9) 0.04
Packed red blood cell (units) 11.3 ± 9.9 14.1 ± 11.3 0.24
Packed red blood cell >10 units 12 (42.9) 28 (63.6) 0.08
Fresh Frozen Plasma (units) 14.5 ± 14.8 22.0 ± 19.1 0.07
Platelets (units) 1.60 ± 1.80 1.75 ± 1.43 0.73
Operation time (hours) 12 (12–14) 13 (12–14) 0.58
LOGISTIC FACTORS
D-MELD at LTx 1067 ± 556 1172 ± 606 0.56
BAR 7.1 ± 4.0 8.8 ± 5.3 0.12
CIT (hours) 8 (7–8) 8 (7–9) 0.23
POST-OPERATIVE ICU FACTORS
SAPS II at the ICU admission 37.8 ± 13.3 41.6 ± 16.9 0.33
PaCO2 pre-extubation (mmHg) 37.4 ± 5.6 38.0 ± 6.1 0.68
PaO2/FiO2 pre-extubation 372 ± 88 337 ± 85 0.13
POST-OPERATIVE SURGICAL FACTORS
MEAF 5.3 ± 2.0 5.9 ± 1.9 0.23
MEAF 8 & over 3 (10.7) 9 (20.5) 0.28
MELD on 3rd p.o.d. (mg/dl) 17.6 ± 6.2 18.9 ± 8.4 0.17
Bilirubin on 3rd p.o.d. (mg/dl) 5.7 ± 4.3 8.0 ± 5.6 0.06
Creatinine on 3rd p.o.d. (mg/dl) 1.32 ± 0.57 1.58 ± 0.73 0.10
OTHER DATA (available after 48 hours)
PaO2 post-extubation (mmHg) 89.0 ± 32.0 113.9 ± 31.6 <0.01
PaCO2 post-extubation (mmHg) 39.2 ± 7.8 39.3 ± 6.1 0.96
PaO2/FiO2 post-extubation 209 ± 93 290 ± 92 <0.01
Mechanical Ventilation (hours) 21 (14–39) 73 (66–119) <0.01
Non-infectious lung involvement 17 (60.7) 36 (81.8) 0.22
Pneumonia 7 (25.0) 13 (29.5) 0.68
Clavien-Dindo Grade 3B and higher 5 (17.9) 23 (52.3) <0.01
LoS in ICU post LTx (days) 9 (7–15) 10 (7–18) 0.81
Death in ICU 1 (3.6) 10 (22.7) 0.03
PRF: Postoperative Respiratory Failure, BMI: body mass index, HCC: Hepatocellular carcinoma, MELD: Model for End-stage Liver Disease, LTx: Liver Transplantation,
VVBP: Veno-Venous bypass, D-MELD: Donor Model for End-stage Liver Disease, BAR: BAlance of Risk score, CIT: Cold Ischemia Time, ICU: Intensive Care Unit,
SAPS: Simplified Acute Physiology Score, PaO2: partial pressure of arterial oxygen, PaCO2: partial pressure of arterial CO2, FiO2: Fraction of Inspired Oxygen, MEAF:
Model for Early Allograft Function, RIFLE: Risk Injury Failure Loss End-stage of kidney disease, LoS: Length of stay.
https://doi.org/10.1371/journal.pone.0211678.t003
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effusion (with or without ascites) causing basal atelectasis. Actually, while ascites is absent or
drained in the early postoperative days, pleural effusion may even worsen due to the lung dys-
function and/or diaphragm trauma.
Regarding VVPB, in our experience it is used in case of high surgical complexity due to var-
ious conditions such as grade-III/IV portal thrombosis, Budd Chiari syndrome, huge liver in
polycystic liver disease, late re-transplant. In addition, we occasionally used VVBP as a rescue
procedure for massive bleeding, when the graft is not yet ready to be implanted (delay in the
organ transport, complex reconstruction on the back table). The proportion of patients receiv-
ing VVBP in our study is comparable to that previously reported [16]. Moreover, in our series
of patients, it can be considered as a surrogate marker of portal hypertension/thrombosis, it is
not collinear with MELD, neither it was routinely used in our high-MELD cases. VVBP pro-
longs per se the operation time, activates fibrinolysis and platelets’ consumption [45]. Although
the operation time showed the highest area under the curve at ROC analysis, VVBP was more
Fig 3. Survival analysis according with the PRF status. Patient survival at 90 days was 97.6%±1.4% in the no-PRF group (continuous line), 96.4%±3.5% in the EF
subgroup (dash-interrupted line), and 79.2%±6.2% in the WF subgroup (dot-interrupted line). Survival was significantly different between PRF and no-PRF groups
(p<0.001) and, within PRF patients, between EF and WF- subgroups (p = 0.047). WF, but not EF patient’ survival, differed from that of no-PRF patients.
https://doi.org/10.1371/journal.pone.0211678.g003
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predictive in all decile categories at the Hosmer-Lemeshow test. We are aware that in centers
not using VVPB, other indicators might be predictive for surgical complexity.
In our population, PRF risk markedly increased along the MEAF score. The association
between graft recovery and PRF has been scarcely investigated. High transaminases have been
associated with PRF [11,18] or PaO2/FiO2�300 mmHg [19]. This is the first study investigat-
ing the PRF impact of the MEAF score, obtained by bilirubin, transaminase and INR, and
ranging continuously from 1 to 10 [29]. More recently, a novel score predicting graft recovery
has been developed, based on bilirubin, transaminase, INR and platelet count [46]. Although
more performant than MEAF, it includes parameters gathered until pod 10, and it is not suit-
able to evaluate PRF at 48 hours.
The mean value of pre-extubation PaCO2, even though still normal, was higher in PRF
patients. This finding has been previously reported [6] and it is conceivable that it results from
a problematic weaning: notwithstanding the exact underlying mechanisms is presently
unknown, the contribution of graft dysfunction/non-function or phrenic and/or diaphrag-
matic surgical trauma cannot be excluded.
As previously reported, we observed a negative prognostic effect for recipient age and
female sex at multivariate analysis [17,47]. It has been suggested that females are less likely to
receive intraoperative low-tidal protective ventilation during surgery, and this may yield a
higher rate of postoperative respiratory complications [47]. Moreover, as compared to male
patients, MELD score in females underestimates liver-kidney dysfunction up to 3 points, prob-
ably for the lower dietary intake and the lower tubular secretion of creatinine [48].
Of note, we failed to demonstrate any impact on the PRF occurrence of diabetes, BMI and,
for the exiguous number of cases, of re-transplant [11–18,49,50].
Noteworthy, we observed that PRF, as usually defined [3,16], includes two populations of
patients with different 90-day survival. Notably, the EF patients exhibited similar overall sur-
vival as no-PRF patients, whereas they did not differ from WF patients regarding main base-
line clinical characteristics and PRF prognostic factors. It could be argued that these patients
may have been extubated a quite bit early, as suggested by their lower post-extubation PaO2/
FiO2. The assessment for readiness for extubation is based on several static measures, even
though the dynamic nature of the weaning makes difficult to definitely predict its success [23].
Indeed, the EF occurs more frequently in patients unable to manage copious tracheal secretion
due to ineffective cough, or respiratory fatigue secondary to poor patient cooperation or mal-
nutrition. However, all these issues cannot be anticipated before extubation. Accordingly, EF
patients compared with WF patients for LoS in ICU, whilst they had a significantly lower
90-day survival.
Although these observations have been gathered in a small subset of patients, we can
hypothesize that EF group represents a low-risk subset of LTx patients, with lower prevalence
of severe complications (Clavien-Dindo grade 3B and over), resulting in better survival. Over-
all, these findings show that differentiating among PRF patients those with EF from those with
WF, can have a significant prognostic relevance.
Our study suffers from some limitations. It is based on a single-center experience, and has a
retrospective design, whereas, to the best of our knowledge, PRF has not been investigated in
multi-center prospective cohorts. According to previous studies, the role of PRF was investi-
gated at 48 hours categorizing PRF as a dichotomic variable.[3–4] Nevertheless, our findings
pave the way to future studies exploring the prognostic role of PRF as a time-dependent s vari-
able. In our series of patients, functional capacity, frailty and sarcopenia were not prospectively
recorded and were not included in the analyses, whereas BMI, a surrogate method to evaluate
sarcopenia, was not predictive. The Dindo-Clavien grading of complications was used instead
of the new Comprehensive Complication Index [51]. Furthermore, we did not test the Donor
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Risk Index [10], which is not applicable in Italy for the shorter distance between donor and
recipient hospitals and higher donor age [52]. Finally, the present study does not include pedi-
atric patients, adult patients transplanted for acute liver failure and living-donor transplants.
The multidisciplinary approach to predict PRF in the complex context of LTx deserves con-
sideration. The methodology adopted may provide hepatologists and surgeons an adequate
tool to estimate the ICU prognosis of listed patients. Patients with high MELD, restrictive lung
pattern and/or high surgical complexity should be informed on their high PRF risk, eventually
increased by early allograft dysfunction. Likewise, our study may help surgeons and intensi-
vists to identify risk-mitigation strategies in specific patients, such as a wider use of non-inva-
sive ventilation soon after the extubation. Accordingly, the frequent use of non-invasive
ventilation, avoiding endotracheal reintubation, can explain the lower pulmonary infection
rate of our population in comparison with other studies [6,16]. In fact, non-invasive ventila-
tion prevents basal atelectasis due to abdominal distension, alteration of diaphragmatic func-
tion and contractility, promotes lung recruitment and decreases work of breathing [24].
Conclusions
On the whole, our analysis carried out according to the organ-based perspective, lung restric-
tive pattern, native liver (MELD), surgical complexity, as captured by VVBP, and new liver
function (MEAF) are the main determinants for PRF in non-acute LTx patients. Remarkably,
donor variables, as evaluated before the transplant, do not always reflect the postoperative
donor-related risk, which can be actually established only in the early postoperative days.
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